Humana Inc. (NYSE:HUM) saw an upside of 0.34% to close Friday at $490.39 after adding $1.65 on the day. The 5-day average trading volume is 835,060 shares of the company’s common stock. It has gained $499.16 in the past week and touched a new high 1 time within the past 5 days. An average of 1,294,600 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,660,212.
HUM’s 1-month performance is 9.61% or $49.66 on its low of $444.94 reached on 07/19/23. The company’s shares have touched a 52-week low of $423.29 and high of $571.30, with the stock’s rally to the 52-week high happening on 05/09/23. YTD, HUM has lost -4.26% or -$21.80 and has reached a new high 8 times. However, the current price is down -14.16% from the 52-week high price.
Insider Transactions
HUM stock investors last saw insider trading activity on May 04.Diamond Susan M (Chief Financial Officer) most recently sold 4,156 shares at $526.28 per share on May 04. This transaction cost the insider $2,187,226. President & CEO, BROUSSARD BRUCE D, sold 17,575 shares at a price of $505.85 on Feb 27. Then, on Feb 27, Chief Administrative Officer Huval Timothy S. sold 2,628 shares at a price of $510.30 per share. This transaction amounted to $1,341,080.
Valuation Metrics
HUM stock has a beta of 0.63. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.61 while the price-to-book (PB) in the most recent quarter is 3.63, with the price to cash flow ratio at 4.98.
As well, the company’s long term debt to equity for the quarter ending June 29 was 0.58, while the total debt to equity was 0.72. The firm’s gross profit as reported stood at $17.18 billion against revenue of $92.87 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 27.42% to $959.0 million, while revenue of $1.24 billion was -29.2% off the previous quarter. Analysts expected HUM to announce $8.82 per share in earnings in its latest quarter, but it posted $8.94, representing a 1.40% surprise. EBITDA for the quarter stood at more than $1.66 billion. HUM stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 39.56 billion, with total debt at $12.2 billion. Shareholders hold equity totaling $123.91 million.
Let’s look briefly at Humana Inc. (HUM) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 62.59% to suggest the stock is trending Neutral, with historical volatility in this time period at 8.05%.
The stock’s 5-day moving average is $493.26, reflecting a -0.71% or -$3.52 change from its current price. HUM is currently trading +7.33% above its 20-day SMA, -3.27% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -2.83% and SMA200 by-12.13%.
Stochastic %K and %D was 81.25% and 86.09% and the average true range (ATR) pointed at 7.95. The RSI (14) points at 62.48%, while the 14-day stochastic is at 77.97% with the period’s ATR at 8.61. The stock’s 9-day MACD Oscillator is pointing at -2.28 and 1.99 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Humana Inc. (NYSE: HUM), JP Morgan downgraded it to a Neutral rating. They previously had an Overweight rating on the stock. Analysts offering their rating for HUM stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate HUM as a “sell,”, while 5 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 16 have offered a “buy” rating.
What is HUM’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $468.00 and a high of $640.00, with their median price target at $589.00. Looking at these predictions, the average price target given by analysts is for Humana Inc. (HUM) stock is $584.05.
